Literature DB >> 17938437

Is the downregulation of EphB2 receptor expression during colorectal tumorigenesis due to hypoxia?

Abderrahmane Kaidi, Morganaden Moorghen, Ann Caroline Williams, Christos Paraskeva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17938437      PMCID： PMC2095662          DOI： 10.1136/gut.2007.131540

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

Review 1.  Wnt signalling in stem cells and cancer.

Authors:  Tannishtha Reya; Hans Clevers
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

2.  EphB receptors coordinate migration and proliferation in the intestinal stem cell niche.

Authors:  Johan Holmberg; Maria Genander; Michael M Halford; Cecilia Annerén; Mariann Sondell; Michael J Chumley; Robert E Silvany; Mark Henkemeyer; Jonas Frisén
Journal:  Cell       Date:  2006-06-16       Impact factor: 41.582

3.  EphB/EphrinB receptors and Wnt signaling in colorectal cancer.

Authors:  Hans Clevers; Eduard Batlle
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

4.  Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia.

Authors:  Abderrahmane Kaidi; Ann Caroline Williams; Christos Paraskeva
Journal:  Nat Cell Biol       Date:  2007-01-14       Impact factor: 28.824

Review 5.  Hypoxia, clonal selection, and the role of HIF-1 in tumor progression.

Authors:  G L Semenza
Journal:  Crit Rev Biochem Mol Biol       Date:  2000       Impact factor: 8.250

Review 6.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

7.  Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB.

Authors:  Eduard Batlle; Jeffrey T Henderson; Harry Beghtel; Maaike M W van den Born; Elena Sancho; Gerwin Huls; Jan Meeldijk; Jennifer Robertson; Marc van de Wetering; Tony Pawson; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

8.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

9.  EphB receptor activity suppresses colorectal cancer progression.

Authors:  Eduard Batlle; Julinor Bacani; Harry Begthel; Suzanne Jonkheer; Suzanne Jonkeer; Alexander Gregorieff; Maaike van de Born; Núria Malats; Elena Sancho; Elles Boon; Tony Pawson; Steven Gallinger; Steven Pals; Hans Clevers
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

10.  Transcriptional response to hypoxia in human tumors.

Authors:  A Lal; H Peters; B St Croix; Z A Haroon; M W Dewhirst; R L Strausberg; J H Kaanders; A J van der Kogel; G J Riggins
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506
  10 in total
  2 in total

1.  Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer.

Authors:  Damian Kołat; Żaneta Kałuzińska; Andrzej K Bednarek; Elżbieta Płuciennik
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

2.  Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis.

Authors:  Alexander Greenhough; Clare Bagley; Kate J Heesom; David B Gurevich; David Gay; Mark Bond; Tracey J Collard; Chris Paraskeva; Paul Martin; Owen J Sansom; Karim Malik; Ann C Williams
Journal:  EMBO Mol Med       Date:  2018-11       Impact factor: 12.137
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.